106 results
Page 3 of 6
6-K
exsty0gl4qrbygutn0vo
21 Dec 22
Current report (foreign)
6:01am
6-K
m2s gmesxgrn544
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
c20qs394
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
ll5t sle1ay
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
xkr0wc22t5j yldzkg0
30 Nov 22
Current report (foreign)
6:28am
6-K
f4wt6mrj54sbura
14 Oct 22
Current report (foreign)
7:36am
6-K
mcr8elb7maxh
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
2qb7rprr nezbrgx9z
23 Aug 22
Current report (foreign)
6:13am
6-K
tj7n1ukv35l
11 Jul 22
Current report (foreign)
6:05am
6-K
duq9s
29 Jun 22
Current report (foreign)
6:02am
6-K
92expx
24 Jun 22
Current report (foreign)
6:08am
6-K
40hkh4yl3zkka2n6py5
1 Jun 22
Current report (foreign)
6:08am
6-K
2hq4 7l5t7hq79v39
31 May 22
Current report (foreign)
6:20am
6-K
EX-99.1
ppzuebiojcy4es11vdni
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
r5gvq3zwme
31 May 22
Current report (foreign)
6:07am
6-K
k4nusgrta3h7id3ops29
11 May 22
Current report (foreign)
6:11am
6-K
yjxy2g14c1hgd hdz
11 May 22
Current report (foreign)
6:06am
6-K
eia90
19 Apr 22
Current report (foreign)
6:07am
6-K
0vnp3u79e5fhld
13 Apr 22
Current report (foreign)
6:41am